IRVINE, Calif., March 08, 2021 – HealthBanks Biotech (USA), Inc. (“HealthBanks” or the “Company”), a premium cell banking network, today announced that through its subsidiary, ImmuneCyte Inc. (“ImmuneCyte”), the Company has executed an acquisition agreement with...
Recent advances in medical research and technology are offering potential therapies for diseases that have plagued humanity for centuries. For the past 15 to 20 years, the discovery of both sources of stem cells and immune cell engineering have demonstrated new...
“Knowledge is Power.” We’ve heard that quote our entire lives, although it’s usually applied to government policies, espionage, and tactics. But while it’s valuable in those situations, the real place it’s best-applied is in science. Look...
IRVINE, Calif. (Dec. 15, 2020) – HealthBanks Biotech, Inc. (the “HealthBanks”), a technological leader in the stem cell banking industry, today introduced the first-of-its-kind, GMP-compliant immune cell banking service for future use in immunotherapies. In the fight...
HealthBanks Kicks Off Holiday Season Launch with $660 Introductory Pricing and a Price Match Guarantee Throughout the holiday season, expecting parents can take advantage of the industry’s best technology at the industry’s best price IRVINE, Calif., Dec. 8, 2020 –...
IRVINE, Calif., Nov 24, 2020 – HealthBanks Biotech, Inc. (the “HealthBanks”), a technological leader in stem cell the banking industry, announces today its change in cord blood banking brand name from Pacificord to HealthBanks. Founded in 2001, HealthBanks...